{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:52:18Z","timestamp":1783475538552,"version":"3.55.0"},"reference-count":61,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"abstract":"<jats:p>To delineate the metabolic fate of thyroid hormone in prolonged critically ill rabbits, we investigated the impact of two dose regimes of thyroid hormone on plasma 3,3\u2032-diiodothyronine (T2) and T4S, deiodinase type 1 (D1) and D3 activity, and tissue iodothyronine levels in liver and kidney, as compared with saline and TRH. D2-expressing tissues were ignored. The regimens comprised either substitution dose or a 3- to 5- fold higher dose of T4 and T3, either alone or combined, targeted to achieve plasma thyroid hormone levels obtained by TRH. Compared with healthy animals, saline-treated ill rabbits revealed lower plasma T3 (P = 0.006), hepatic T3 (P = 0.02), and hepatic D1 activity (P = 0.01). Substitution-dosed thyroid hormone therapy did not affect these changes except a further decline in plasma (P = 0.0006) and tissue T4 (P = 0.04). High-dosed thyroid hormone therapy elevated plasma and tissue iodothyronine levels and hepatic D1 activity, as did TRH. Changes in iodothyronine tissue levels mimicked changes in plasma. Tissue T3 and tissue T3\/reverse T3 ratio correlated with deiodinase activities. Neither substitution- nor high-dose treatment altered plasma T2. Plasma T4S was increased only by T4 in high dose. We conclude that in prolonged critically ill rabbits, low plasma T3 levels were associated with low liver and kidney T3 levels. Restoration of plasma and liver and kidney tissue iodothyronine levels was not achieved by thyroid hormone in substitution dose but instead required severalfold this dose. This indicates thyroid hormone hypermetabolism, which in this model of critical illness is not entirely explained by deiodination or by sulfoconjugation.<\/jats:p>","DOI":"10.1210\/en.2007-1566","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T04:48:49Z","timestamp":1209876529000},"page":"4218-4228","source":"Crossref","is-referenced-by-count":23,"title":["Effects of Substitution and High-Dose Thyroid Hormone Therapy on Deiodination, Sulfoconjugation, and Tissue Thyroid Hormone Levels in Prolonged Critically Ill Rabbits"],"prefix":"10.1210","volume":"149","author":[{"given":"Yves","family":"Debaveye","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine (Y.D., B.E., L.M., G.V.d.B.), Catholic University of Leuven, B-3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjo\u0308rn","family":"Ellger","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine (Y.D., B.E., L.M., G.V.d.B.), Catholic University of Leuven, B-3000 Leuven, Belgium"},{"name":"Department of Anesthesiology and Intensive Care Medicine (B.E.), University Hospital of Muenster, D-48149 Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liese","family":"Mebis","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine (Y.D., B.E., L.M., G.V.d.B.), Catholic University of Leuven, B-3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo J.","family":"Visser","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine (Y.D., B.E., L.M., G.V.d.B.), Catholic University of Leuven, B-3000 Leuven, Belgium"},{"name":"Department of Internal Medicine (T.J.V.), Erasmus University Medical Center, 3015 GE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle M.","family":"Darras","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine (Y.D., B.E., L.M., G.V.d.B.), Catholic University of Leuven, B-3000 Leuven, Belgium"},{"name":"Laboratory of Comparative Endocrinology (V.M.D.), Catholic University of Leuven, B-3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"Van den Berghe","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine (Y.D., B.E., L.M., G.V.d.B.), Catholic University of Leuven, B-3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2008,5,1]]},"reference":[{"key":"2020071612510981200_R1","first-page":"246","author":"Wiersinga","year":"2005"},{"key":"2020071612510981200_R2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejim.2004.10.014","article-title":"Endocrine interventions in the ICU.","volume":"16","author":"Ellger","year":"2005","journal-title":"Eur J Intern Med"},{"key":"2020071612510981200_R3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0091-3022(02)00006-7","article-title":"Dynamic neuroendocrine responses to critical illness.","volume":"23","author":"Van den Berghe","year":"2002","journal-title":"Front Neuroendocrinol"},{"key":"2020071612510981200_R4","first-page":"4032","article-title":"Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness.","volume":"82","author":"Fliers","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R5","first-page":"309","article-title":"Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.","volume":"83","author":"Van den Berghe","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R6","first-page":"1311","article-title":"Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness.","volume":"84","author":"Van den Berghe","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1210\/jcem-53-4-764","article-title":"Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses.","volume":"53","author":"Kaptein","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R8","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1210\/jcem-41-6-1043","article-title":"Reciprocal changes in serum concentrations of 3,3\u2032,5-triiodothyronine (T3) in systemic illnesses.","volume":"41","author":"Chopra","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/cc4613","article-title":"Regulation of type 1 deiodinase activity in prolonged critical illness.","volume":"10","author":"Debaveye","year":"2007","journal-title":"Crit Care"},{"key":"2020071612510981200_R10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jcem-63-1-1","article-title":"Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration.","volume":"63","author":"Brent","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R11","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00003246-198212000-00014","article-title":"Hypermetabolic low triiodothyronine syndrome of burn injury.","volume":"10","author":"Becker","year":"1982","journal-title":"Crit Care Med"},{"key":"2020071612510981200_R12","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1210\/en.2005-0963","article-title":"Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2.","volume":"146","author":"Debaveye","year":"2005","journal-title":"Endocrinology"},{"key":"2020071612510981200_R13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jcem.84.1.5364","article-title":"Dangerous dogmas in medicine: the nonthyroidal illness syndrome.","volume":"84","author":"DeGroot","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/edrv.23.1.0455","article-title":"Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.","volume":"23","author":"Bianco","year":"2002","journal-title":"Endocr Rev"},{"key":"2020071612510981200_R15","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1210\/jc.2002-022013","article-title":"Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients.","volume":"88","author":"Peeters","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R16","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.2005-0535","article-title":"Serum 3,3\u2032,5\u2032-triiodothyronine (rT3) and 3,5,3\u2032-triiodothyronine\/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities.","volume":"90","author":"Peeters","year":"2005","journal-title":"J Clin Endocrinol Metab 2005"},{"key":"2020071612510981200_R17","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1210\/jc.2005-0866","article-title":"Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity.","volume":"90","author":"Peeters","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R18","first-page":"189","article-title":"A radioimmunoassay for measurement of 3,5,3\u2032-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life.","volume":"75","author":"Chopra","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/thy.2005.15.943","article-title":"Alternate pathways of thyroid hormone metabolism.","volume":"15","author":"Wu","year":"2005","journal-title":"Thyroid"},{"key":"2020071612510981200_R20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1210\/endo.143.3.8664","article-title":"A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response.","volume":"143","author":"Weekers","year":"2002","journal-title":"Endocrinology"},{"key":"2020071612510981200_R21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jcem-47-6-1311","article-title":"The production and metabolism of 3,5,3\u2032-triiodothyronine and 3,3\u2032,5-triiodothyronine in normal and fasting subjects.","volume":"47","author":"Suda","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1210\/en.2003-1005","article-title":"Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness.","volume":"145","author":"Weekers","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612510981200_R23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1210\/endo-103-4-1434","article-title":"Serum concentrations, metabolic clearance rates, and production rates of reverse triiodothyronine, triiodothyronine, and thyroxine in starved rabbits.","volume":"103","author":"Takagi","year":"1978","journal-title":"Endocrinology"},{"key":"2020071612510981200_R24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1677\/joe.0.1060087","article-title":"Iodothyronine kinetics in the rabbit: an experimental model.","volume":"106","author":"Pearce","year":"1985","journal-title":"J Endocrinol"},{"key":"2020071612510981200_R25","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1210\/en.2003-0697","article-title":"Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness.","volume":"144","author":"Weekers","year":"2003","journal-title":"Endocrinology"},{"key":"2020071612510981200_R26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/gcen.1996.0163","article-title":"Plasma thyroid hormone levels and iodothyronine deiodinase activity following an acute glucocorticoid challenge in embryonic compared with posthatch chickens.","volume":"104","author":"Darras","year":"1996","journal-title":"Gen Comp Endocrinol"},{"key":"2020071612510981200_R27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1677\/joe.0.0730395","article-title":"Radioimmunoassay of reverse tri-iodothyronine.","volume":"73","author":"Visser","year":"1977","journal-title":"J Endocrinol"},{"key":"2020071612510981200_R28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jcem-29-8-1015","article-title":"Influence of heparin on serum free thyroxine.","volume":"29","author":"Schatz","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1677\/joe.0.0790357","article-title":"Radioimmunoassay of 3,3\u2032-di-iodothyronine in unextracted serum: the effect of endogenous tri-iodothyronine.","volume":"79","author":"Visser","year":"1978","journal-title":"J Endocrinol"},{"key":"2020071612510981200_R30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/15321818808057036","article-title":"Development of a radioimmunoassay for triiodothyronine sulfate.","volume":"9","author":"Eelkman Rooda","year":"1988","journal-title":"J Immunoassay"},{"key":"2020071612510981200_R31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.44.467","article-title":"Increased urinary thyroxine sulfate excretion in thyroxine therapy.","volume":"44","author":"Huang","year":"1997","journal-title":"Endocr J"},{"key":"2020071612510981200_R32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/002367793781082412","article-title":"Removal of blood from laboratory mammals and birds. First report of the BVA\/FRAME\/RSPCA\/UFAW Joint Working Group on Refinement.","volume":"27","author":"Morton","year":"1993","journal-title":"Lab Anim"},{"key":"2020071612510981200_R33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1096-4959(01)00528-0","article-title":"Changes in thyroid hormone levels in chicken liver during fasting and refeeding.","volume":"132","author":"Reyns","year":"2002","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"2020071612510981200_R34","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1210\/endo-117-5-1890","article-title":"Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function.","volume":"117","author":"Morreale de Escobar","year":"1985","journal-title":"Endocrinology"},{"key":"2020071612510981200_R35","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/endo-94-4-1060","article-title":"Concentration of thyroxine in cellular and extracellular tissues of the sheep and the rate of equilibration of labeled thyroxine.","volume":"94","author":"Irvine","year":"1974","journal-title":"Endocrinology"},{"key":"2020071612510981200_R36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0300-9629(92)90252-L","article-title":"Ontogeny of type I and type III deiodinase activities in embryonic and posthatch chicks: relationship with changes in plasma triiodothyronine and growth hormone levels.","volume":"103","author":"Darras","year":"1992","journal-title":"Comp Biochem Physiol Comp Physiol"},{"key":"2020071612510981200_R37","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1172\/JCI25083","article-title":"Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans.","volume":"115","author":"Maia","year":"2005","journal-title":"J Clin Invest"},{"key":"2020071612510981200_R38","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1210\/jcem-65-4-606","article-title":"Thyroxine transfer and distribution in critical nonthyroidal illnesses, chronic renal failure, and chronic ethanol abuse.","volume":"65","author":"Kaptein","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI110278","article-title":"Thyroid hormone metabolism in primary cultured rat hepatocytes. Effects of glucose, glucagon, and insulin.","volume":"68","author":"Sato","year":"1981","journal-title":"J Clin Invest"},{"key":"2020071612510981200_R40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1210\/endo-117-1-8","article-title":"Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase.","volume":"117","author":"Mol","year":"1985","journal-title":"Endocrinology"},{"key":"2020071612510981200_R41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jcem-67-1-17","article-title":"Deiodination of thyroid hormone by human liver.","volume":"67","author":"Visser","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R42","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/endo-125-4-2175","article-title":"Effects of propylthiouracil on the biliary clearance of thyroxine (T4) in rats: decreased excretion of 3,5,3\u2032-triiodothyronine glucuronide and increased excretion of 3,3\u2032,5\u2032-triiodothyronine glucuronide and T4 sulfate.","volume":"125","author":"Rutgers","year":"1989","journal-title":"Endocrinology"},{"key":"2020071612510981200_R43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/edrv-12-2-135","article-title":"The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland.","volume":"12","author":"Curran","year":"1991","journal-title":"Endocr Rev"},{"key":"2020071612510981200_R44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1046\/j.1365-2265.1997.3371118.x","article-title":"Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.","volume":"47","author":"Van den Berghe","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612510981200_R45","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI107014","article-title":"Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones.","volume":"51","author":"Snyder","year":"1972","journal-title":"J Clin Invest"},{"key":"2020071612510981200_R46","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/0026-0495(93)90266-Q","article-title":"Reduced tissue thyroid hormone levels in fatal illness.","volume":"42","author":"Arem","year":"1993","journal-title":"Metabolism"},{"key":"2020071612510981200_R47","first-page":"502","article-title":"Tissue thyroid hormone concentration of rat and man determined by radiommunoassay: biologic significance.","volume":"40","author":"Reichlin","year":"1973","journal-title":"Mt Sinai J Med"},{"key":"2020071612510981200_R48","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI111138","article-title":"Sources and quantity of 3,5,3\u2032-triiodothyronine in several tissues of the rat.","volume":"72","author":"Doorn","year":"1983","journal-title":"J Clin Invest"},{"key":"2020071612510981200_R49","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1172\/JCI109041","article-title":"Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.","volume":"61","author":"Silva","year":"1978","journal-title":"J Clin Invest"},{"key":"2020071612510981200_R50","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1210\/endo-103-4-1196","article-title":"The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3\u2032-triiodothyronine in pituitary, liver, and kidney of euthyroid rats.","volume":"103","author":"Silva","year":"1978","journal-title":"Endocrinology"},{"key":"2020071612510981200_R51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/edrv-2-1-87","article-title":"Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications.","volume":"2","author":"Larsen","year":"1981","journal-title":"Endocr Rev"},{"key":"2020071612510981200_R52","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/endo.133.4.8404614","article-title":"Pretranslational regulation of type I 5\u2032-deiodinase by thyroid hormones and in fasted and diabetic rats.","volume":"133","author":"O'Mara","year":"1993","journal-title":"Endocrinology"},{"key":"2020071612510981200_R53","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1210\/jc.2005-1013","article-title":"Tissue thyroid hormone levels in critical illness.","volume":"90","author":"Peeters","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R54","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/en.2004-1392","article-title":"Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse.","volume":"146","author":"Zavacki","year":"2005","journal-title":"Endocrinology"},{"key":"2020071612510981200_R55","first-page":"467","article-title":"Distinct tissue-specific roles for thyroid hormone receptors \u03b2 and \u03b11 in regulation of type 1 deiodinase expression.","volume":"15","author":"Amma","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2020071612510981200_R56","first-page":"2364","article-title":"Impaired thyroxine and 3,5,3\u2032-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness.","volume":"80","author":"Vos","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612510981200_R57","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1210\/endo-120-5-2144","article-title":"Diabetes decreases liver and kidney nuclear 3,5,3\u2032-triiodothyronine receptors in rats.","volume":"120","author":"Jolin","year":"1987","journal-title":"Endocrinology"},{"key":"2020071612510981200_R58","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2265.2002.01255.x","article-title":"The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.","volume":"56","author":"Van den Berghe","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612510981200_R59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1677\/joe.0.1180417","article-title":"The influence of plasma concentrations of tri-iodothyronine on the acute increases in insulin and muscle protein synthesis in the refed fasted rat.","volume":"118","author":"Millward","year":"1988","journal-title":"J Endocrinol"},{"key":"2020071612510981200_R60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/en.2005-0739","article-title":"Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice.","volume":"147","author":"Schneider","year":"2006","journal-title":"Endocrinology"},{"key":"2020071612510981200_R61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/acta.0.0990079","article-title":"Alterations in hepatic nuclear binding of triiodothyronine in experimental diabetes mellitus in rats.","volume":"99","author":"Wiersinga","year":"1982","journal-title":"Acta Endocrinol (Copenh)"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/8\/4218\/9004145\/endo4218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/8\/4218\/9004145\/endo4218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T22:07:30Z","timestamp":1594937250000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/149\/8\/4218\/2455748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,1]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2007-1566","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,1]]}}}